Major Indian drug makers Cipla, Glenmark recall products from US market over manufacturing lapses
Jammu, May 5 -- Major Pharma Companies Recall Medications Due to Manufacturing Issues
In a recent notification by the US Food and Drug Administration (USFDA), two major Indian pharmaceutical companies Cipla and Glenmark have recalled certain medications from the American market owing to manufacturing defects.
As per reports, a New Jersey based subsidiary of Mumbai headquartered drug maker Cipla is recalling over 59 thousand packs of a combination inhalation solution used commonly to treat respiratory illnesses like asthma. The affected products were manufactured at Cipla's Indore facility in Madhya Pradesh. USFDA noted the recall was initiated in March this year due to complaints of under-filled vials and liquid observed outside the sea...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.